Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2/3 1

Status

Recruiting 7Completed 3Withdrawn 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Classical hematology 1

Conditions

Breast Neoplasms 681Neoplasms 593Carcinoma, Non-Small-Cell Lung 292Colorectal Neoplasms 291Prostatic Neoplasms 284Lung Neoplasms 224Melanoma 161Multiple Myeloma 151Neoplasm Metastasis 145Pancreatic Neoplasms 143Head and Neck Neoplasms 143Ovarian Neoplasms 136Carcinoma, Hepatocellular 126Leukemia, Myeloid, Acute 122Colonic Neoplasms 114Brain Neoplasms 113Squamous Cell Carcinoma of Head and Neck 111Uterine Cervical Neoplasms 109Stomach Neoplasms 104Lymphoma 101Recurrence 100Glioblastoma 96Precursor Cell Lymphoblastic Leukemia-Lymphoma 83Lymphoma, Non-Hodgkin 82Urinary Bladder Neoplasms 78Lymphoma, Follicular 78Hematologic Neoplasms 78Glioma 75Parkinson Disease 4, Autosomal Dominant Lewy Body 73Sarcoma 72

Interventions

sotrovimab 1ciclesonide 1Niclosamide 1High-Intensity Interval Training 1Exercise 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Lupus Erythematosus, Systemic × 1 year × Clear all
NCT05478018 2025-09-09

LUPEX

Rigshospitalet, Denmark

Phase NA Completed
55 enrolled

Lupus Erythematosus, Systemic

NCT03938324 2025-07-28

PiCASO

Duke University

Phase NA Completed
222 enrolled 11 charts
Classical hematology

Anemia, Sickle Cell, Cystic Fibrosis, Diabetes Mellitus, Type 1, Lupus Erythematosus, Systemic, Neoplasms, Inflammatory Bowel Diseases, Renal Insufficiency, Chronic

NCT04870333 2025-06-20

PROTECT-V

Cambridge University Hospitals NHS Foundation Trust

Phase 2/3 Completed
2,240 enrolled

COVID-19, Glomerulonephritis, Lupus Erythematosus, Systemic, Neoplasms, Vasculitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡